Development and validation of risk stratification and shared decision-making tool for catheter ablation for atrial fibrillation in patients with heart failure: a multicentre cohort study
Authors:
Open Access
- 28 April 2025
- journal article
- Published by Elsevier in eClinicalMedicine
- Vol. 83, 103219
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Atrial Fibrillation Ablation in Heart Failure With Reduced vs Preserved Ejection FractionJAMA Cardiology, 2024
- Reporting Use of AI in Research and Scholarly Publication—JAMA Network GuidanceJAMA, 2024
- Heart Failure with Preserved Ejection Fraction Phenogroup Classification Using Machine LearningESC Heart Failure, 2023
- Gender-Specific Prevalence and Trend of Heart Failure in China from 1990 to 2019ESC Heart Failure, 2023
- Clustering Based on Comorbidities in Patients with Chronic Heart Failure: An Illustration of Clinical DiversityESC Heart Failure, 2021
- Clinical Phenogroups are More Effective than Left Ventricular Ejection Fraction Categories in Stratifying Heart Failure OutcomesESC Heart Failure, 2021
- Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fractionEuropean Journal of Heart Failure, 2021
- Phenomapping of Patients with Heart Failure with Preserved Ejection Fraction Using Machine Learning-Based Unsupervised Cluster AnalysisEuropean Journal of Heart Failure, 2019
- Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial FibrillationJAMA, 2019
- Association of of Atrial Fibrillation Clinical Phenotypes With Treatment Patterns and OutcomesJAMA Cardiology, 2018